about
Pain related to cancer treatments and diagnostic procedures: a no man's land?Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents.Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.Head and neck tumors other than squamous cell carcinoma.Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer PatientsAdvances in the changing patterns of aetiology of head and neck cancers.Respiratory illness and air pollution from the steel industry: the case of Piquiá de Baixo, Brazil (Preliminary report).Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis.Emerging tyrosine kinase inhibitors for head and neck cancer.Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review.Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus.Gastrointestinal toxicities from targeted therapies: measurement, duration and impact.Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.The role of systemic therapy in the management of sinonasal cancer: A critical review.Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis.Sinonasal Malignancies of Anterior Skull Base: Histology-driven Treatment Strategies.An Environment for Guideline-based Decision Support Systems for Outpatients Monitoring.Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations.Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling.Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.Investigational drugs for head and neck cancer.Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer.Prognostic and predictive value of EGFR in head and neck squamous cell carcinomaSmoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer.Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy.Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy.The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity.Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.
P50
Q27026749-BEE58674-D351-4C0C-B1AE-DE538400DDECQ30249335-9B25FD72-FBD2-40C0-AC78-6AF5DED625B1Q30650708-B6A1F571-7DE2-412F-A51A-8FC8A0B604F3Q30820418-D7BD333F-CF97-4022-8520-45B70398B8D8Q34658767-44017A92-C7A0-44F7-BAD9-2890D0C15C4DQ35682431-F8A9D009-41F9-4283-94DD-A46FD5DC1BC9Q35740075-3B0B5FF8-181F-402A-B1C9-67757A789D64Q36191292-5173755B-869E-4BD9-B789-FDF9578F4E4BQ36427965-CE57E2C2-14B5-4073-BE77-CB75A5570D84Q37402986-2C43CB2D-4B19-42E6-A6A2-39C699309780Q37541446-B4518AD4-6F86-4DDA-A371-A2C4E6927355Q38103465-F5C273CD-7242-475F-AEA8-C63B546DF614Q38149327-F24EFDC2-D2F4-4DF0-A57F-FFF8FDE9573EQ38272767-8CA7F569-7352-4277-84F1-C91B5CA078C1Q38282447-709313D6-24C9-4D08-9456-24166A5F9C6AQ38367277-0B88F726-FF8D-4680-9967-986C5B57FA1EQ38394241-5C50ECD3-A36E-4BDC-8020-A1361CC4B3C3Q38420385-57A23755-6A9D-4CDB-BD2D-7BBB223AEE2CQ38549597-725A0326-84AA-4C62-B9D3-052FD6973F83Q38563054-40C77989-6FC9-40CF-A038-75EA52F3C6BCQ38575922-B34211C6-5D1F-43D1-A800-8D6C027B97A4Q38576080-87F79284-BFB0-450A-AF01-2ECE7CC707F2Q38651314-99720D9D-9EF2-4089-9BED-35C5B46D6676Q38670548-60026AE1-6490-44BD-A9E1-3B22128A3E7CQ38681954-50436685-C4A5-46A3-A3FA-6E5B3100A54DQ38746932-ECB52E0E-6243-4871-B29B-84BCF55AA9BAQ38755840-F944BF84-ED11-4578-AC3D-9C08D2891504Q38762722-D2806BEC-008E-4031-B523-3318C4BC2D37Q38800788-82AD2BDD-E960-400B-9641-71B298B32BF2Q38803186-33A50DF3-DD80-42DD-977E-765B28522478Q38926574-0BAD2834-D6B7-42A5-9415-C6CE9371C8CFQ38935842-286CC183-651E-4D4A-9945-DE85A0D9A2F0Q38948795-E89D8ED1-53EC-460E-828D-8B43F2F6A6B2Q39015086-8F0EF47C-C543-4F58-9F11-8EFC3BD8C0F1Q39027285-60E5F229-B190-4257-9F38-E630C25E21BBQ39085400-7C5C88F4-07FD-4DC9-9046-C0F6259C47AAQ39156639-0E0EB9C2-AC5F-4B16-BDDC-853D09085EB4Q39253334-DED8F479-ECCE-4812-AC9A-C6F2BF1C18ADQ39426352-293960E4-B882-47CB-8761-FD3B251E444CQ39501001-C641936C-DDC4-4700-92F9-4528DD95E813
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Bossi
@ast
Paolo Bossi
@en
Paolo Bossi
@es
Paolo Bossi
@nl
Paolo Bossi
@sl
type
label
Paolo Bossi
@ast
Paolo Bossi
@en
Paolo Bossi
@es
Paolo Bossi
@nl
Paolo Bossi
@sl
prefLabel
Paolo Bossi
@ast
Paolo Bossi
@en
Paolo Bossi
@es
Paolo Bossi
@nl
Paolo Bossi
@sl
P1053
D-1807-2017
P106
P1153
23092932500
P21
P31
P3829
P496
0000-0003-0135-0224